AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

President Donald Trump signed an executive order creating a Women’s Health Division at the NIH and a White House task force to coordinate research across agencies. The order rescinds a 2023 Biden initiative but sets no specific funding goals; the administration says it will promote research into conditions affecting women across their lives.

President Donald Trump signed an executive order Monday creating a Women’s Health Division at the National Institutes of Health and a separate White House task force, with the stated aim of improving research into women’s health across their lives. The order also rescinds a 2023 Biden administration initiative and does not specify funding targets.

The order calls for expanded federal research into maternal health, mental health, endometriosis, infertility, fibroids and menopause. It also identifies Alzheimer’s disease, heart disease, osteoporosis and stroke among the health concerns to be addressed. The White House says the new NIH division is intended to improve coordination of government research; the order also points to diagnostic technology and treatment as areas for advancement.

White House chief of staff Susie Wiles and Health Secretary Robert F. Kennedy Jr. will lead the task force, according to the report. Trump said the panel would coordinate with federal agencies and programs. Its first meeting was scheduled for Monday, the day the order was signed. The administration said its approach would use artificial intelligence and a government-wide task force, which it described as going beyond the earlier Biden effort.

The order follows meetings between first lady Melania Trump, the president, Kennedy and other federal health officials. Melania Trump said the initiative would focus on finding cures and improving women’s health. Trump said the order would promote research into diseases affecting women that he described as understudied. Those statements express the administration’s aims; the order itself does not set a budget, a funding commitment or a timetable for research results.

At a glance
announcementWhen: Signed Monday, October 19, 2026; task f…
The developmentTrump signed an executive order creating new federal structures for women’s health research and rescinding a Biden-era initiative.

How Federal Research Could Change

The order could reshape how federal agencies coordinate research into conditions that affect women, including diseases and life stages named in the directive. Establishing an NIH division and a White House task force gives the administration new structures to pursue that work. Whether these structures produce more research or better treatments will depend in part on funding, agency implementation and scientific progress.

The lack of specific funding goals leaves a key question unanswered: how much additional support, if any, will reach researchers. The change also arrives amid broader cuts to federal scientific research, including grants that have been targeted over diversity-related criteria, according to the report. The order’s practical effect will depend on how the new bodies operate alongside existing programs and whether research funding is sustained.

Amazon

women's health research books

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Biden Initiative and Existing NIH Office

The order replaces a federal initiative launched in 2023 by President Joe Biden, whose administration said it was improving how the government approached and funded women’s health research. Before leaving office, the Bidens said the initiative had attracted nearly $1 billion in federal funding, including money from the Defense Department and NIH. That figure was reported as the initiative’s funding total; it does not establish how much of that support the new order will preserve or replace.

The NIH already has an Office of Research on Women’s Health, established in 1990 to advance understanding of biological and social factors affecting women’s health and disease, according to the office’s website. The new division is presented by the White House as a way to improve coordination, but the source report did not detail how its responsibilities will differ from the existing office.

The Biden initiative and Monday’s order follow wider debate over federal support for women’s health research. The Trump administration previously announced that the long-running Women’s Health Initiative would close early, then reversed that decision after protests, according to the report. The latest order’s relationship to other federal research programs and policies remains a point of scrutiny.

“Beginning today we will change the reality of women’s health.”

— First lady Melania Trump

Funding and Program Overlap

The order provides no specific funding goals, and the source report does not say whether agencies will receive new appropriations or redirect existing budgets. It is also unclear how the new NIH division will divide responsibilities with the NIH’s existing Office of Research on Women’s Health, or how the task force will measure progress and report results.

The report also says it was unclear whether the order conflicts with earlier Trump administration actions curtailing programs and policies focused on diversity, equity and inclusion. Those actions have included cuts to scientific grants with a diversity focus, while the new directive calls for expanded women’s health research. How the administration will reconcile those policies has not been explained.

Task Force Begins Its Work

The White House task force was scheduled to hold its first meeting on Monday, October 19. Its work with federal agencies and programs is the next step described in the announcement. The source report did not provide a schedule for later meetings, identify research projects to be funded or give deadlines for the NIH division to become operational.

Readers can expect the practical reach of the order to become clearer as the administration sets out implementation details, including any funding decisions, agency responsibilities and measures for tracking progress. Until those details are released, the order establishes a policy direction and new structures, but not a specified level of research spending or a timetable for results.

Key Questions

What did Trump’s executive order establish?

It creates a Women’s Health Division at the NIH and a separate White House task force intended to coordinate federal work on women’s health research.

Which health topics does the order name?

The order identifies maternal and mental health, endometriosis, infertility, fibroids and menopause, as well as Alzheimer’s disease, heart disease, osteoporosis and stroke.

Does the order provide new research funding?

The order does not set specific funding goals. The report does not establish whether new money will be allocated or how existing research budgets may be used.

What happens to the Biden administration’s initiative?

Trump’s order rescinds the 2023 initiative. The Biden administration had said it attracted nearly $1 billion in federal funding, but the order does not specify how much of that funding or related work will continue.

Who will lead the White House task force?

White House chief of staff Susie Wiles and Health Secretary Robert F. Kennedy Jr. will lead it, according to the report.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
HALLOWEEN

Halloween Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Why We Should Never Retire From Being Useful

A Sixty and Me opinion piece argues that older adults can keep contributing after retirement through mentoring, volunteering and everyday support.

Levothyroxine Recall 2026

The FDA has announced a recall of certain levothyroxine sodium tablets in 2026 due to quality concerns, affecting thousands of patients nationwide.

Sanford Bemidji Surges In Global Coverage

Sanford Bemidji hospital experiences a surge in international coverage, with 20 mentions in recent media tracking, marking a notable increase in global attention.

Should DayQuil Be Legal?

Discussions are ongoing about whether DayQuil should be legalized, amid concerns over misuse and regulatory challenges. Here’s what is known now.